Abiopharma

Acadia Pharmaceuticals Appoints Scott Cenci as Chief Information and Data Officer

Mineralys Therapeutics to Announce Second Quarter 2025 Financial Results and Host Conference Call on Tuesday, August 12, 2025

New Form D - InspireMD, Inc. Filed: 2025-08-04 AccNo: 0001641172-25-022037 Size: 16 KB

New Form SCHEDULE 13G/A - MYRIAD GENETICS INC Filed: 2025-08-04 AccNo: 0001104659-25-073620 Size: 18 KB

OrthoPediatrics Corp. to Participate in the 45th Canaccord Genuity Annual Growth Conference

Prothena - Prothena Reports Second Quarter 2025 Financial Results and Business Highlights

New Form 8-K - BIOMARIN PHARMACEUTICAL INC Filed: 2025-08-04 AccNo: 0001048477-25-000088 Size: 810 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - Semler Scientific, Inc. Filed: 2025-08-04 AccNo: 0001554859-25-000042 Size: 743 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 4 - Quanterix Corp Filed: 2025-08-04 AccNo: 0001562180-25-005615 Size: 8 KB

New Form 144 - Twist Bioscience Corp Filed: 2025-08-04 AccNo: 0001959173-25-004923 Size: 7 KB

New Form 144 - IONIS PHARMACEUTICALS INC Filed: 2025-08-04 AccNo: 0001972481-25-000157 Size: 9 KB

New Form 8-K - Syndax Pharmaceuticals Inc Filed: 2025-08-04 AccNo: 0000950170-25-101974 Size: 7 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Inspire Medical Systems, Inc. - Inspire Medical Systems, Inc. Announces Second Quarter 2025 Financial Results and Updates 2025 Outlook

Ardelyx Reports Second Quarter 2025 Financial Results and Provides Business Update

Semler Scientific® Reports Second Quarter 2025 Financial Results, BTC Holdings of 5,021 and BTC Yield of 31.3% YTD through July 31, 2025